$305.33
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Country

US

CEO

Mr. Norman Schwartz

IPO date

1980

Employees

7,450

ISIN

US0905722072

Key stats

Open

$0.00

Volume

61.00

Market cap

$7.70B

Prev. close

$304.14

Impl / hst vl

-

Open interest

$0.00

$0.00

Day’s Range

$0.00

$244.54

52W Range

$310.70

Valuation

55
Valuation score
Fairly Valued
P/E
44.56
P/S
2.90
P/B
1.10
Current ratio
3.21
Debt / Equity
0.10
ROE
2.40%
Gross margin
52.25%
Income growth
-173.21%
FCF growth
-34.42

Analysts estimates

Consensus rating
Buy

The average rating from top 4 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$324.65
The top 9 analysts forecasts that 12-month price may increase by 6.33%, with a low of $287.03 and a high of $363.50
$287.03
Low
$324.65
Avg
$363.50
High
Current price

Earnings

Q1 ‘26 revenue
$592.10M
Q1 ‘26 net income
-$527.10M
Revenue
Net income
Previous EPS
$2.51
Estimate EPS
$2.00
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply